SECTORS TODAY
Tech XLK -4.89%
Financials XLF -0.76%
Healthcare XLV +0.45%
Energy XLE +1.91%
Industrials XLI -1.60%
Cons. Disc. XLY -0.71%
Cons. Staples XLP +1.41%
Utilities XLU +0.67%
Materials XLB +0.40%
Real Estate XLRE +0.26%
Comm. Svcs XLC -1.29%

Earnings release · FDXF

FedEx Freight Reports Solid Financial Results for the

FedEx Freight Holding Company, Inc. · Filed · SEC Form 8-K, Item 2.02

FedEx Freight Holding Company, Inc. company page Original on SEC.gov ↗

Revenue — +9.2% vs a year ago
EPS $1.54 not detected
Guidance issuedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete. Please read the original before relying on any figure. Not investment advice.

Why it matters

Revenue increased 9.2% year on year, and EPS was $1.54. The company issued new guidance, which gives a first marker for expectations in the periods ahead.

Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.

What the company states

Revenue

n/a +9.2% vs a year ago

…FedEx Freight revenue increased 9.2% year-over-year for the four months ended September 30, 2026.…
EPS

$1.54

…Diluted EPS of $1.54, a 43% decrease; adjusted diluted EPS of $2.15, a 24.6% decrease…
Guidance

Guidance issued

…Introduces Positive Outlook for Three Months Ending December 31, 2026.…

Read the original press release on SEC.gov ↗ Filing index ↗

Compared with the previous report

Aug 6, 2026 →
Previous (Aug 6)This releaseChange
Revenue growth (YoY)—+9.2%—
EPS growth (YoY)———
Guidance—issued—

“pts” = percentage points of year-over-year growth, current release minus previous release.

Other releases from FedEx Freight Holding Company, Inc.

All →
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.

Get new research in your inbox

Forensic equity research on US stocks. No spam, unsubscribe anytime.